Xylometazoline is a potent topical nasal decongestant that acts directly on α-adrenergic receptors in the nasal mucosa, inducing vasoconstriction to reduce blood flow and nasal congestion. It alleviates congestion and edema caused by inflammation and is clinically used to relieve nasal obstruction associated with acute and chronic rhinitis, sinusitis, allergic rhinitis, and hypertrophic rhinitis. It is characterized by rapid onset, prolonged duration of action, minimal side effects, and low potential for rebound congestion. As a direct α1-adrenergic receptor agonist, xylometazoline is employed as a nasal decongestant to improve symptoms of nasal congestion, allergic rhinitis, and sinusitis.